Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor' versus 'no donor' comparison

被引:43
作者
Mohty, M. [1 ,2 ,3 ,4 ]
de Lavallade, H. [1 ]
El-Cheikh, J. [1 ,2 ]
Ladaique, P. [5 ]
Faucher, C. [1 ,2 ]
Fuerst, S. [1 ,2 ]
Vey, N. [2 ]
Coso, D. [2 ]
Stoppa, A-M [2 ]
Gastaut, J-A [2 ]
Chabannon, C. [5 ]
Blaise, D. [1 ,2 ,3 ,4 ]
机构
[1] Inst J Paoli I Calmettes, UTTC, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France
[3] Univ Mediterranee, Fac Med, Marseille, France
[4] INSERM, UMR 599, F-13258 Marseille, France
[5] Inst J Paoli I Calmettes, CTCG, F-13009 Marseille, France
关键词
REMISSION;
D O I
10.1038/leu.2008.164
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:194 / 196
页数:5
相关论文
共 10 条
[1]   Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia [J].
Blaise, Didier ;
Vey, Norbert ;
Faucher, Catherine ;
Mohty, Mohamad .
HAEMATOLOGICA, 2007, 92 (04) :533-541
[2]  
Champlin R, 1999, ONCOLOGY-NY, V13, P621
[3]   Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors [J].
Hegenbart, U ;
Niederwieser, D ;
Sandmaier, BM ;
Maris, MB ;
Shizuru, JA ;
Greinix, H ;
Cordonnier, C ;
Rio, B ;
Gratwohl, A ;
Lange, T ;
Al-Ali, H ;
Storer, B ;
Maloney, D ;
McSweeney, P ;
Chauncey, T ;
Agura, E ;
Bruno, B ;
Maziarz, RT ;
Petersen, F ;
Storb, R .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) :444-453
[4]   Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct [J].
Lazarus, H. M. ;
Rowe, J. M. .
LEUKEMIA, 2006, 20 (10) :1673-1682
[5]   Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using BLA-identical sibling donors in myelodysplastic syndromes [J].
Martino, Rodrigo ;
Iacobelli, Simona ;
Brand, Ronald ;
Jansen, Thekla ;
van Biezen, Anja ;
Finke, Jurgen ;
Bacigalupo, Andrea ;
Beelen, Dietrich ;
Reiffers, Jossy ;
Devergie, Agnes ;
Alessandrino, Emilie ;
Mufti, Ghulam J. ;
Barge, Renee ;
Sierra, Jorge ;
Ruutu, Tapani ;
Boogaerts, Marc ;
Falda, Michele ;
Jouet, Jean-Pierre ;
Niederwieser, Dieter ;
de Witte, Theo .
BLOOD, 2006, 108 (03) :836-846
[6]   The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia:: a donor vs no donor comparison [J].
Mohty, M ;
de Lavallade, H ;
Ladaique, P ;
Faucher, C ;
Vey, N ;
Coso, D ;
Stoppa, AM ;
Gastaut, JA ;
Blaise, D .
LEUKEMIA, 2005, 19 (06) :916-920
[7]   Allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia in first complete remission: new answers for an old question [J].
Shimoni, A ;
Nagler, A .
LEUKEMIA, 2005, 19 (06) :891-893
[8]   Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences [J].
Sorror, Mohamed L. ;
Giralt, Sergio ;
Sandmaier, Brenda M. ;
De Lima, Marcos ;
Shahjahan, Munir ;
Maloney, David G. ;
Deeg, H. Joachim ;
Appelbaum, Frederick R. ;
Storer, Barry ;
Storb, Rainer .
BLOOD, 2007, 110 (13) :4606-4613
[9]   Can reduced-intensity allogeneic transplantation cure older adults with AML? [J].
Storb, Rainer .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (01) :85-90
[10]   Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation:: Chronic graft-versus-host disease is the strongest factor improving survival [J].
Valcarel, David ;
Martino, Rodrigo ;
Caballero, Dolores ;
Martin, Jesus ;
Ferra, Christelle ;
Nieto, Jose B. ;
Sampol, Antonia ;
Bernal, M. Teresa ;
Pinana, Jose L. ;
Vazquez, Lourdes ;
Ribera, Jose M. ;
Besalduch, Joan ;
Moraleda, Jose M. ;
Carrera, Dolores ;
Brunet, M. Salut ;
Perez-Simon, Jose A. ;
Sierra, Jorge .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :577-584